Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Neuroderm Ltd Ord Sh (NDRM)

Neuroderm Ltd Ord Sh (NDRM)
38.85 -0.05 (-0.13%) 10/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Tue, Oct 17th, 2017
Day Low
38.85
Day High
38.95
Open 38.90
Previous Close 38.90 38.90
Volume 200,900 200,900
Avg Vol 252,855 252,855
Stochastic %K 50.00% 50.00%
Weighted Alpha +75.10 +75.10
5-Day Change unch (unch) unch (unch)
52-Week Range 15.20 - 38.95 15.20 - 38.95
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,023,698
  • Shares Outstanding, K 26,350
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,500 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.77
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.97
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.56
  • Most Recent Earnings $-0.25 on 05/11/17
  • Next Earnings Date 11/09/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate -0.49
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.56
  • Prior Year -0.42
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.80 +0.13%
on 09/19/17
Period Open: 38.85
38.95 -0.26%
on 10/17/17
unch (unch)
since 09/15/17
3-Month
30.70 +26.55%
on 07/18/17
Period Open: 31.25
38.95 -0.26%
on 10/17/17
+7.60 (+24.32%)
since 07/17/17
52-Week
15.20 +155.59%
on 12/01/16
Period Open: 17.35
38.95 -0.26%
on 10/17/17
+21.50 (+123.92%)
since 10/17/16

Business Summary

Neuroderm Ltd. is a clinical-stage pharmaceutical company. It is developing next-generation treatments for central nervous system (CNS) disorders. The Company develops liquid levodopa (LD), which is a treatment for Parkinson's disease (PD). Its product pipelines includes ND0612L for moderate PD, ND0612H...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 38.98
1st Resistance Point 38.92
Last Price 38.85
1st Support Level 38.82
2nd Support Level 38.78
3rd Support Level N/A

See More

52-Week High 38.95
Last Price 38.85
Fibonacci 61.8% 29.88
Fibonacci 50% 27.08
Fibonacci 38.2% 24.27
52-Week Low 15.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals